Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2754265 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 14 Pages |
Abstract
Patients with MGUS follow-up preceding the diagnosis of a monoclonal gammopathy-associated malignancy can experience fewer major complications and have longer survival than those without such follow-up examinations. Future studies replicating our findings in the non-Medicare population and determining the optimal schedule and cost-effectiveness of MGUS follow-up are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ronald S. Go, Jacob D. Gundrum, Joan M. Neuner,